Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...

Discover the Dr. Reddy's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.26% to 6,630.85 Indian rupees Tuesday, on what proved to be an ...

The head of India's market regulator and her husband are answering allegations of conflict of interest raised by the main ...

Facing off against oral drugs such as AbbVie’s Ubrelvy, Tonix is seeking to raise awareness of potential benefits of nasal ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.38% to 6,658.60 Indian rupees Friday, on what proved to be an ...

In a stock filing, Dr Reddy's Laboratories acknowledged payments to Dhaval Buch for coaching services but rejected conflict ...

Indian automaker Mahindra & Mahindra and pharmaceutical company Dr Reddy's Laboratories said on Tuesday they had paid the ...

Dr Reddy’s Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in multiple strengths, the US health regulator said in its latest enforcement report.

Dr. Reddy's Laboratories and Lupin are pulling back their pharmaceutical products from the US market, following manufacturing deficiencies highlighted by the US Food and Drug Administration (USFDA).

In a filing with the exchanges, Dr Reddy's Laboratories said that the NMPA China recently conducted a remote inspection of the firm's formulations manufacturing facility for Atomoxetine ...

On Monday, September 2, Dr. Reddy’s Laboratories Ltd. saw its share prices fall following an import, sale, and use suspension imposed by the National Medical Products Administration (NMPA ...